94 related articles for article (PubMed ID: 10086700)
1. Staging and monitoring of malignant lymphoma of the bone: comparison of 67Ga scintigraphy and MRI.
Stroszczynski C; Oellinger J; Hosten N; Spahn G; Amthauer H; Ricke J; Hoffmann KT; Eichstaedt H; Ludwig WD; Felix R
J Nucl Med; 1999 Mar; 40(3):387-93. PubMed ID: 10086700
[TBL] [Abstract][Full Text] [Related]
2. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
3. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
Moog F; Kotzerke J; Reske SN
J Nucl Med; 1999 Sep; 40(9):1407-13. PubMed ID: 10492357
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
Mouratidis B; Gilday DL; Ash JM
Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
[TBL] [Abstract][Full Text] [Related]
5. Gallium-67 scintigraphy in lymphoma with bone involvement.
Bar-Shalom R; Israel O; Epelbaum R; Haim N; Ben-Arush M; Ben-Shachar M; Leviov M; Gaitini D; Ben-Haim S; Even-Sapir E
J Nucl Med; 1995 Mar; 36(3):446-50. PubMed ID: 7884507
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of 67Ga scintigraphy in extranodal malignant lymphoma patients.
Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Nagai M; Ohkawa M
Ann Nucl Med; 2003 Dec; 17(8):657-62. PubMed ID: 14971607
[TBL] [Abstract][Full Text] [Related]
9. A comparison of 111In-octreotide and 67Ga scintigraphy in malignant lymphoma.
Cerulus G; Léonard JP
Nucl Med Commun; 1997 Jul; 18(7):616-22. PubMed ID: 9342098
[TBL] [Abstract][Full Text] [Related]
10. Multifocal primary lymphoma of bone: scintigraphy and MR findings before and after treatment.
Yuki M; Narabayashi I; Yamamoto K; Shimizu T; Tanaka Y; Tatsumi T; Komori T
Radiat Med; 2000; 18(5):305-10. PubMed ID: 11128401
[TBL] [Abstract][Full Text] [Related]
11. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma.
Lee JK; Tsai SC; Ho YJ; Changlai SP; Kao CH
Anticancer Res; 2001; 21(2B):1509-13. PubMed ID: 11396241
[TBL] [Abstract][Full Text] [Related]
13. The value of 99mTc-MDP bone scintigraphy in staging primary lymphoma of bone.
O'Connor AR; Birchall JD; O'Connor SR; Bessell E
Nucl Med Commun; 2007 Jul; 28(7):529-31. PubMed ID: 17538393
[TBL] [Abstract][Full Text] [Related]
14. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
15. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
[TBL] [Abstract][Full Text] [Related]
16. Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative study.
Bar-Shalom R; Yefremov N; Haim N; Dann EJ; Epelbaum R; Keidar Z; Gaitini D; Frenkel A; Israel O
Radiology; 2003 May; 227(2):353-60. PubMed ID: 12637679
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.
Yilmaz MH; Ozguroglu M; Mert D; Turna H; Demir G; Adaletli I; Ulus S; Halac M; Kanberoğlu K
Med Oncol; 2008; 25(3):257-63. PubMed ID: 18040900
[TBL] [Abstract][Full Text] [Related]
18. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma of the skeleton: scintigraphic evaluation.
Orzel JA; Sawaf NW; Richardson ML
AJR Am J Roentgenol; 1988 May; 150(5):1095-9. PubMed ID: 3258711
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.
Balliu E; Boada M; Peláez I; Vilanova JC; Barceló-Vidal C; Rubio A; Galofré P; Castro A; Pedraza S
Clin Radiol; 2010 Dec; 65(12):989-96. PubMed ID: 21070903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
